Monitoring and Assessment Program (MAP)

The COVID-19 Monitoring and Assessment Program (MAP) ended on June 30, 2023 and the last day of operation was June 22.

For questions or to request results until July 31st, email c19map@uoregon.edu. This email is monitored Monday-Friday.

MAP was created in spring 2020 to develop and expand the university’s testing capacity for the coronavirus that causes COVID-19.

The program leveraged the research strengths of the UO, including experts in genomics, data science, prevention science, and other areas.

MAP Tests Provided

MAP Goals

  1. Develop a fully operational clinical laboratory improvement amendments (CLIA)-certified testing laboratory on campus.

  2. Create test collection and test processing systems to provide capacity for screening and surveillance testing for COVID-19 at UO and its surrounding community.

  3. Use the results of the testing to develop strategies that local officials and university leaders can enact to reduce the spread of COVID-19 as activity and population changes occur.

Sample Collection Methods

  • Self-collected saliva—in use
     
  • Self-collected shallow nasal swab (anterior nares)—in use
     
  • Deep nasal swab—approved, but not in use

Sample Processing Methods

  • DiaCarta QuantiVirus SARS-CoV-2 quantitative PCR (qPCR) – in use

  • Genotyping by RNA sequencing, and high throughput RNA-seq of entire viral genomes—in use

  • Saliva Direct—in use

  • SwabSeq—optimized but not in use